AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10
Amyris, Inc. (Nasdaq: AMRS) will announce its financial results for Q1 2022 on May 10, 2022, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amyris, Inc. (Nasdaq: AMRS) will announce its financial results for Q1 2022 on May 10, 2022, before market opening. A conference call is scheduled for 6:00 a.m. PT (9:00 a.m. ET) where CEO John Melo and CFO Han Kieftenbeld will discuss the results and business updates. Amyris utilizes its Lab-to-Market™ platform to transition the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients, reaching over 300 million consumers with products in more than 20,000 brand offerings.
Positive
- Scheduled financial results announcement for Q1 2022, providing transparency to investors.
- Utilization of Lab-to-Market™ technology to drive innovation in sustainable ingredients.
Negative
- None.
Details
News Market Reaction – AMRS
The recorded move for AMRS in the trading session of this news was +2.22%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, today announced that it will issue its financial results for the first quarter ended March 31, 2022, on the morning of Tuesday, May 10, 2022, prior to the opening of the financial markets.
The company will hold a conference call and webcast at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), during which, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss Amyris' financial results and provide an update on the company's business. Participants may access the live webcast on Amyris' Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing (844) 850-0551 (domestic) or (412) 902-4203 (international) and asking to join the Amyris, Inc. call.
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content:https://www.prnewswire.com/news-releases/amyris-to-host-first-quarter-2022-financial-results-conference-call-on-may-10-301538285.html
SOURCE Amyris, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.